文献速递腹部妇产影像CT

高级别浆液性卵巢癌:BRCA突变状态、CT影像表型与临床结局之间的关联

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.
PubMed 文献 · Radiology · 2017-06-16

本回顾性研究纳入108例高级别浆液性卵巢癌患者(BRCA突变33例、BRCA野生型75例),术前CT由两名放射科医师独立评估。结果显示腹膜病变分布等CT特征与BRCA突变状态相关,且预测不满意减灭的CT指标因BRCA状态而异;肠系膜受累在两组的均与更短无进展生存期相关。

要点

  • BRCA突变型与野生型HGSOC的CT腹膜病变分布模式不同,腹膜病变模式、胃肝韧带受累、肠系膜受累及膈上淋巴结增大与BRCA状态相关。
  • BRCA野生型中,小网膜囊腹膜病变、左上腹腹膜病变、肠系膜受累及膈上/肾上腹主动脉旁淋巴结增大与不满意减灭几率升高相关。
  • 肠系膜受累在BRCA突变型与野生型中均与显著更短的无进展生存期相关。

核心结论

  • BRCA突变型与野生型HGSOC患者的定性CT特征存在差异;预测减灭结局的CT指标因BRCA突变状态而异;肠系膜受累在两组中均提示显著更短的无进展生存期。

研究设计与样本

  • HIPAA合规、经机构审查委员会批准的回顾性研究,纳入108例HGSOC患者(BRCA突变33例、BRCA野生型75例),均为初次减灭术前接受CT检查;两名放射科医师独立评估定性CT特征,采用logistic回归和Cox比例风险回归分析关联。

关键影像表现/征象

  • 腹膜病变模式、胃肝韧带腹膜病变、肠系膜受累及膈上淋巴结增大在CT上与BRCA突变状态相关(多元回归每项CT特征P < .001)。

诊断标准与关键数值

  • BRCA野生型HGSOC中,小网膜囊腹膜病变OR = 2.40、左上腹腹膜病变OR = 1.19、肠系膜受累OR = 7.10、膈上淋巴结增大OR = 2.83、肾上腹主动脉旁淋巴结增大OR = 4.79,均与不满意减灭几率升高相关(多元回归每项CT特征P < .001)。
  • BRCA突变型HGSOC中,肠系膜受累与更短PFS相关(多元回归HR = 26.7,P < .001)。
  • BRCA野生型HGSOC中,肠系膜受累与更短PFS相关(单因素分析:读者1 HR = 2.42,P < .001;读者2 HR = 2.61,P < .001)。
  • BRCA突变型HGSOC中,临床与CT特征与减灭结局无关联。

临床应用与阅片要点

  • 阅片时可关注腹膜病变分布模式、胃肝韧带、小网膜囊、左上腹、肠系膜及膈上/肾上腹主动脉旁淋巴结等部位,这些特征与BRCA状态或减灭结局相关。
  • 报告肠系膜受累时需注意,其在BRCA突变型与野生型中均与更短PFS相关。
  • 预测减灭结局的CT指标需结合BRCA突变状态解读,不同状态下的相关指标不同。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate the associations between BRCA mutation status and computed tomography (CT) phenotypes of high-grade serous ovarian cancer (HGSOC) and to evaluate CT indicators of cytoreductive outcome and survival in patients with BRCA-mutant HGSOC and those with BRCA wild-type HGSOC. Materials and Methods This HIPAA-compliant, institutional review board-approved retrospective study included 108 patients (33 with BRCA mutant and 75 with BRCA wild-type HGSOC) who underwent CT before primary debulking. Two radiologists independently reviewed the CT findings for various qualitative CT features. Associations between CT features, BRCA mutation status, cytoreductive outcome, and progression-free survival (PFS) were evaluated by using logistic regression and Cox proportional hazards regression, respectively. Results Peritoneal disease (PD) pattern, presence of PD in gastrohepatic ligament, mesenteric involvement, and supradiaphragmatic lymphadenopathy at CT were associated with BRCA mutation status (multiple regression: P < .001 for each CT feature). While clinical and CT features were not associated with cytoreductive outcome for patients with BRCA-mutant HGSOC, presence of PD in lesser sac (odds ratio [OR] = 2.40) and left upper quadrant (OR = 1.19), mesenteric involvement (OR = 7.10), and lymphadenopathy in supradiaphragmatic (OR = 2.83) and suprarenal para-aortic (OR = 4.79) regions were associated with higher odds of incomplete cytoreduction in BRCA wild-type HGSOC (multiple regression: P < .001 each CT feature). Mesenteric involvement at CT was associated with significantly shorter PFS for both patients with BRCA-mutant HGSOC (multiple regression: hazard ratio [HR] = 26.7 P < .001) and those with BRCA wild-type HGSOC (univariate analysis: reader 1, HR = 2.42, P < .001; reader 2, HR = 2.61; P < .001). Conclusion Qualitative CT features differed between patients with BRCA-mutant HGSOC and patients with BRCA wild-type HGSOC. CT indicators of cytoreductive outcome varied according to BRCA mutation status. Mesenteric involvement at CT was an indicator of significantly shorter PFS for both patients with BRCA-mutant HGSOC and those with BRCA wild-type HGSOC. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Nougaret S, Lakhman Y, Gönen M, et al. High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes. Radiology. 2017. PMID: 28628421. doi:10.1148/radiol.2017161697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。